|
DE10252667A1
(de)
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
|
US7767689B2
(en)
*
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
EA201200555A1
(ru)
|
2004-03-15 |
2013-01-30 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Производные карболина, полезные в ингибировании ангиогенеза
|
|
EP1831225A2
(en)
|
2004-11-19 |
2007-09-12 |
The Regents of the University of California |
Anti-inflammatory pyrazolopyrimidines
|
|
DE102005016460A1
(de)
*
|
2005-04-11 |
2006-10-19 |
Grünenthal GmbH |
Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
|
|
MX2007015905A
(es)
|
2005-06-24 |
2008-03-06 |
Lilly Co Eli |
Derivados de tetrahidrocarbazol utiles como moduladores de receptor de androgeno (sarm).
|
|
WO2007062175A2
(en)
*
|
2005-11-21 |
2007-05-31 |
Amgen Inc. |
Spiro-substituted tricyclic heterocycles cxcr3 antagonists
|
|
RS55940B1
(sr)
|
2005-12-28 |
2017-09-29 |
Vertex Pharma |
Čvrsti oblici n-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksohinolin-3-karboksamida
|
|
KR20090017498A
(ko)
|
2006-04-04 |
2009-02-18 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
Ｐｉ３ 키나제 길항물질
|
|
UA99257C2
(ru)
|
2006-07-19 |
2012-08-10 |
Е.І. Дю Пон Де Немур Енд Компані |
Способ получения 3-замещенных 2-амино-5-галогенбензамидов
|
|
ITMI20061581A1
(it)
*
|
2006-08-04 |
2008-02-05 |
Univ Bari |
Ligandi del recettore beta-3 adrenergico e loro uso in terapia
|
|
UA98777C2
(en)
|
2006-11-20 |
2012-06-25 |
Эли Лилли Энд Компани |
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
|
|
DE102007009235A1
(de)
*
|
2007-02-22 |
2008-09-18 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
WO2009042907A1
(en)
*
|
2007-09-27 |
2009-04-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
|
|
WO2009046448A1
(en)
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Chemical entities and therapeutic uses thereof
|
|
JP5366211B2
(ja)
|
2007-12-18 |
2013-12-11 |
国立大学法人富山大学 |
アルドース還元酵素阻害活性を有する縮合三環化合物
|
|
WO2009088990A1
(en)
|
2008-01-04 |
2009-07-16 |
Intellikine, Inc. |
Certain chemical entities, compositions and methods
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
EP2252293B1
(en)
|
2008-03-14 |
2018-06-27 |
Intellikine, LLC |
Kinase inhibitors and methods of use
|
|
US8357705B2
(en)
|
2008-03-27 |
2013-01-22 |
Gruenenthal Gmbh |
Substituted cyclohexyldiamines
|
|
CL2009000731A1
(es)
|
2008-03-27 |
2009-05-15 |
Gruenenthal Gmbh |
Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.
|
|
JP5599774B2
(ja)
|
2008-03-27 |
2014-10-01 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
ヒドロキシメチルシクロヘキシルアミン類
|
|
ES2694103T3
(es)
|
2008-03-27 |
2018-12-18 |
Grünenthal GmbH |
Derivados de 4-aminociclohexano sustituidos
|
|
PL2257526T3
(pl)
|
2008-03-27 |
2012-05-31 |
Gruenenthal Gmbh |
Pochodne spiro (5.5) undekanu
|
|
BRPI0912394A2
(pt)
|
2008-05-16 |
2016-07-26 |
Lilly Co Eli |
moduladores do receptor de androgênio à base de tetra-hidrociclopenta[b]indol
|
|
BRPI0915231A2
(pt)
|
2008-07-08 |
2018-06-12 |
Intellikine Inc |
compostos inibidores de quinase e métodos de uso
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
CA2738429C
(en)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
DK2358720T3
(en)
|
2008-10-16 |
2016-06-06 |
Univ California |
Heteroarylkinaseinhibitorer fused-ring
|
|
US8476282B2
(en)
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
|
WO2010056309A2
(en)
*
|
2008-11-14 |
2010-05-20 |
The Scripps Research Institute |
Methods and compositions related to targeting monoacylglycerol lipase
|
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
|
WO2010138685A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
ES2826950T3
(es)
|
2009-05-27 |
2021-05-19 |
Ptc Therapeutics Inc |
Métodos para tratar cáncer y afecciones no neoplásicas
|
|
US8697662B2
(en)
|
2009-05-27 |
2014-04-15 |
Ptc Therapeutics, Inc. |
Methods for treating Kaposi sarcoma
|
|
WO2010138644A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Processes for the preparation of substituted tetrahydro beta-carbolines
|
|
IN2012DN00352A
(enExample)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
CN102574787B
(zh)
|
2009-07-30 |
2014-12-31 |
新加坡国立大学 |
具有潜在的抗癌活性的小分子异戊二烯基半胱氨酸羧基甲基转移酶抑制剂
|
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
|
RU2550821C2
(ru)
*
|
2009-10-29 |
2015-05-20 |
Сертрис Фармасьютикалз, Инк. |
Бициклические пиридины и аналоги в качестве модуляторов сиртуина
|
|
EP2531029B1
(en)
*
|
2010-02-04 |
2016-10-19 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
|
WO2011143469A1
(en)
|
2010-05-12 |
2011-11-17 |
Radius Health,Inc |
Therapeutic regimens
|
|
US8604032B2
(en)
|
2010-05-21 |
2013-12-10 |
Infinity Pharmaceuticals, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
WO2011155983A1
(en)
*
|
2010-06-07 |
2011-12-15 |
Bikam Pharmaceuticals Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP3578205A1
(en)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
|
BR112013007685B1
(pt)
|
2010-09-28 |
2021-11-09 |
Radius Pharmaceuticals, Inc |
Compostos moduladores de receptor andrógeno seletivos, composição farmacêutica compreendendo os referidos compostos, método de identificação de um composto capaz de modular um receptor andrógeno, usos de um composto ou da composição e processo para a preparação de um composto
|
|
CN103429606A
(zh)
|
2010-10-01 |
2013-12-04 |
现代治疗公司 |
设计核酸及其使用方法
|
|
EP2637669A4
(en)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and their use
|
|
US8980924B2
(en)
|
2010-11-24 |
2015-03-17 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
|
GB201021103D0
(en)
*
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
|
NZ612909A
(en)
|
2011-01-10 |
2015-09-25 |
Infinity Pharmaceuticals Inc |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
|
JPWO2012105610A1
(ja)
*
|
2011-02-02 |
2014-07-03 |
株式会社三和化学研究所 |
眼内血管新生及び／又は眼内血管透過性亢進を伴う疾患の予防又は治療のための医薬
|
|
TWI592411B
(zh)
|
2011-02-23 |
2017-07-21 |
英特爾立秦有限責任公司 |
激酶抑制劑之組合及其用途
|
|
ES2587856T3
(es)
|
2011-03-18 |
2016-10-27 |
Ono Pharmaceutical Co., Ltd. |
Derivado de tetrahidrocarbolina
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
TWI565709B
(zh)
|
2011-07-19 |
2017-01-11 |
英菲尼提製藥股份有限公司 |
雜環化合物及其用途
|
|
EP2734520B1
(en)
|
2011-07-19 |
2016-09-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
RU2014111823A
(ru)
|
2011-08-29 |
2015-10-10 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения и их применения
|
|
WO2013077921A2
(en)
|
2011-09-02 |
2013-05-30 |
The Regents Of The University Of California |
Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CN103030643B
(zh)
*
|
2011-09-29 |
2015-04-29 |
中国科学院化学研究所 |
六环吲哚类生物碱及其制备方法
|
|
KR20190099538A
(ko)
|
2011-10-03 |
2019-08-27 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드, 및 핵산, 및 이들의 용도
|
|
AR088377A1
(es)
|
2011-10-20 |
2014-05-28 |
Siena Biotech Spa |
Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
|
|
EP4144378A1
(en)
|
2011-12-16 |
2023-03-08 |
ModernaTX, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
EP2606726A1
(de)
|
2011-12-21 |
2013-06-26 |
Bayer CropScience AG |
N-Arylamidine-substituierte trifluoroethylsulfid-Derivate als Akarizide und Insektizide
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
AU2013243954A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
AU2013243949A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2013166037A1
(en)
|
2012-05-01 |
2013-11-07 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of eye disorders
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
EP2690091A1
(en)
|
2012-07-25 |
2014-01-29 |
Studiengesellschaft Kohle mbH |
Process for preparing substituted indole derivatives
|
|
US20150210717A1
(en)
*
|
2012-09-13 |
2015-07-30 |
Baden-Württemberg Stiftung Gmbh |
Specific inhibitors of protein p21 as therapeutic agents
|
|
KR20150061651A
(ko)
|
2012-09-26 |
2015-06-04 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
Ire1의 조절
|
|
CA2890105C
(en)
|
2012-11-01 |
2023-03-21 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
DK2922554T3
(en)
|
2012-11-26 |
2022-05-23 |
Modernatx Inc |
Terminalt modificeret rna
|
|
WO2014151936A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles, their preparation and use
|
|
ES2705247T3
(es)
|
2013-03-14 |
2019-03-22 |
Univ Columbia |
4-fenilpiperidinas, su preparación y uso
|
|
WO2014151959A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
|
EP2968303B1
(en)
|
2013-03-14 |
2018-07-04 |
The Trustees of Columbia University in the City of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
JP2016516804A
(ja)
|
2013-04-17 |
2016-06-09 |
ファイザー・インク |
心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
|
|
US10561707B2
(en)
*
|
2013-09-08 |
2020-02-18 |
Technion Research And Development Foundation Ltd. |
Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
BR112016007255A2
(pt)
|
2013-10-03 |
2017-09-12 |
Moderna Therapeutics Inc |
polinucleotídeos que codificam receptor de lipoproteína de baixa densidade
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
SG10201902074UA
(en)
|
2013-10-04 |
2019-04-29 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
|
CN113616656B
(zh)
|
2014-03-19 |
2023-02-17 |
无限药品股份有限公司 |
用于治疗PI3K-γ介导的障碍的杂环化合物
|
|
SG11201608303QA
(en)
|
2014-04-04 |
2016-11-29 |
Del Mar Pharmaceuticals |
Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
CN111393434B
(zh)
|
2014-04-30 |
2022-11-04 |
哥伦比亚大学董事会 |
取代的4-苯基哌啶及其制备和用途
|
|
KR20250004174A
(ko)
|
2014-06-27 |
2025-01-07 |
노그라 파마 리미티드 |
아릴 수용체 조정제, 및 그의 제조 및 사용 방법
|
|
US20170210788A1
(en)
|
2014-07-23 |
2017-07-27 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
US10570146B2
(en)
*
|
2014-07-25 |
2020-02-25 |
Northeastern University |
Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof
|
|
EP3193600A4
(en)
*
|
2014-09-10 |
2018-05-23 |
Epizyme, Inc. |
Smyd inhibitors
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
RU2749213C2
(ru)
|
2014-10-07 |
2021-06-07 |
Вертекс Фармасьютикалз Инкорпорейтед |
Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе
|
|
PT3319959T
(pt)
|
2015-07-06 |
2021-12-06 |
Alkermes Inc |
Inibidores hetero-halo de histona desacetilase
|
|
WO2017007755A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
AU2016322552B2
(en)
|
2015-09-14 |
2021-03-25 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
|
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
JP7221699B2
(ja)
|
2016-06-22 |
2023-02-14 |
エリプセス ファーマ エルティーディー |
Ａｒ＋乳癌の治療方法
|
|
WO2017223422A1
(en)
|
2016-06-24 |
2017-12-28 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
DK3484528T3
(da)
|
2016-07-18 |
2021-02-15 |
Janssen Pharmaceutica Nv |
Tau-pet-billeddannelsesligander
|
|
CA3035001C
(en)
|
2016-08-26 |
2025-05-27 |
Sumitomo Chemical Company, Limited |
COMPOUND OF PHENYL UREA AND ITS USES
|
|
CN109563041B
(zh)
|
2016-08-26 |
2021-12-07 |
住友化学株式会社 |
1-乙酰基-3-苯基脲化合物及其用途
|
|
KR20190093205A
(ko)
|
2016-12-21 |
2019-08-08 |
바이오테릭스, 인코포레이티드 |
단백질 표적화에 사용하기 위한 티에노피롤 유도체, 조성물, 방법 및 이의 용도
|
|
MX394242B
(es)
|
2017-01-11 |
2025-03-24 |
Rodin Therapeutics Inc |
Inhibidores biciclicos de histona desacetilasa
|
|
MX2019010717A
(es)
|
2017-03-10 |
2019-12-05 |
Univ Rutgers |
Derivados de indol como inhibidores de bomba de eflujo.
|
|
US11180459B2
(en)
|
2017-03-10 |
2021-11-23 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
WO2018165614A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
WO2018218192A1
(en)
|
2017-05-26 |
2018-11-29 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
EP3638215A4
(en)
|
2017-06-15 |
2021-03-24 |
Modernatx, Inc. |
RNA FORMULATIONS
|
|
US11458121B2
(en)
|
2017-06-26 |
2022-10-04 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds and methods to treat infection
|
|
KR20200035292A
(ko)
|
2017-08-01 |
2020-04-02 |
피티씨 테라퓨틱스, 인크. |
혈액 암 치료에 사용하기 위한 dhodh 억제제
|
|
MX2020001484A
(es)
|
2017-08-07 |
2020-08-20 |
Rodin Therapeutics Inc |
Inhibidores bicíclicos de la histona desacetilasa.
|
|
CN111315359A
(zh)
|
2017-08-31 |
2020-06-19 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
US10882821B1
(en)
|
2017-09-26 |
2021-01-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes
|
|
WO2019140188A1
(en)
|
2018-01-11 |
2019-07-18 |
Centaurus Therapeutics |
Inhibitors of dihydroceramide desaturase for treating disease
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
EP4267578A4
(en)
|
2020-12-23 |
2024-11-20 |
Recurium IP Holdings, LLC |
ESTROGEN RECEPTOR MODULATORS
|
|
US20250034089A1
(en)
*
|
2021-11-19 |
2025-01-30 |
Nain Biotech (Hangzhou) Co., Ltd. |
Tetrahydrocarbazole compound, and pharmaceutical composition and use thereof
|
|
WO2024230729A1
(zh)
|
2023-05-10 |
2024-11-14 |
杭州拿因生物科技有限责任公司 |
四氢咔唑衍生物、其药物组合物及用途
|